Results showed that the effect of PAC treatment on prostate cancer is mainly achieved through reducing the expression of AR and inhibiting the inflammatory microenvironment in vivo, finally inhibiting prostate cancerproliferation and inducing prostate cancer apoptosis. This evidence concerns the gene AR and Familial prostate cancer.